FDA Drug information
Budesonide Inhalation Suspension
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Budesonide Inhalation Suspension BUDESONIDE .25 mg/2mL Exelan Pharmaceuticals, Inc.
- Budesonide Inhalation Suspension BUDESONIDE .25 mg/2mL NorthStar RxLLC
- Budesonide Inhalation Suspension BUDESONIDE .25 mg/2mL Preferred Pharmaceuticals Inc.
- Budesonide Inhalation Suspension BUDESONIDE .5 mg/2mL Exelan Pharmaceuticals, Inc.
- Budesonide Inhalation Suspension BUDESONIDE .5 mg/2mL NorthStar RxLLC
- Budesonide Inhalation Suspension BUDESONIDE .5 mg/2mL Preferred Pharmaceuticals Inc.
- Budesonide Inhalation Suspension BUDESONIDE 1 mg/2mL Exelan Pharmaceuticals, Inc.
- Budesonide Inhalation Suspension BUDESONIDE 1 mg/2mL NorthStar RxLLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.